The import of antisera and other blood fractions to Brazil is projected to grow steadily from 2024 through 2028, with the forecasted values showing an incremental increase each year. This consistent upward trend signals strong and ongoing demand within the healthcare sector in Brazil. In 2023, the actual import value stood at an unspecified figure; however, based on the provided forecasts, a steady year-on-year increase is evident leading to a cumulative average growth rate over five years.

Key future trends to monitor include:

Emerging healthcare needs and policies in Brazil, which could impact import levels.
Technological advancements in blood fraction products possibly affecting demand.
Global economic conditions influencing import-export dynamics.
Fluctuations in the US Dollar exchange rate that could impact the cost of imports.